Vectus Biosystems logo

VBS - Vectus Biosystems News Story

A$1.47 0.0  0.7%

Last Trade - 3:49am

Sector
Healthcare
Size
Micro Cap
Market Cap £24.5m
Enterprise Value £25.5m
Revenue £43.3k
Position in Universe 1203rd / 1957

BRIEF-Vectus Biosystems Announces Successful Convertible Note Issue To Raise $7 Million

Tue 17th September, 2019 9:21am
Sept 17 (Reuters) - Vectus Biosystems Ltd  VBS.AX :
    * ANNOUNCES A SUCCESSFUL CONVERTIBLE NOTE ISSUE TO RAISE AN
AMOUNT
OF $7 MILLION
    * FUNDS WILL BE USED TO COMPLETE PHASE I CLINICAL TRIALS FOR
VB0004, WHICH POTENTIALLY PREVENTS & REVERSES FIBROSIS IN ORGANS

Source text for Eikon:  urn:newsml:reuters.com:*:nASX6RqWNW
Further company coverage:  VBS.AX 

 (Reporting by Pranav A K)
 ((Pranav.AK@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.